Elsevier

Annals of Emergency Medicine

Volume 70, Issue 3, September 2017, Pages 406-418.e4
Annals of Emergency Medicine

Pulmonary/original research
Lung-Protective Ventilation Initiated in the Emergency Department (LOV-ED): A Quasi-Experimental, Before-After Trial

Presented at the American Thoracic Society Conference, May 2016, San Francisco, CA.
https://doi.org/10.1016/j.annemergmed.2017.01.013Get rights and content

Study objective

We evaluated the efficacy of an emergency department (ED)–based lung-protective mechanical ventilation protocol for the prevention of pulmonary complications.

Methods

This was a quasi-experimental, before-after study that consisted of a preintervention period, a run-in period of approximately 6 months, and a prospective intervention period. The intervention was a multifaceted ED-based mechanical ventilator protocol targeting lung-protective tidal volume, appropriate setting of positive end-expiratory pressure, rapid oxygen weaning, and head-of-bed elevation. A propensity score–matched analysis was used to evaluate the primary outcome, which was the composite incidence of acute respiratory distress syndrome and ventilator-associated conditions.

Results

A total of 1,192 patients in the preintervention group and 513 patients in the intervention group were included. Lung-protective ventilation increased by 48.4% in the intervention group. In the propensity score–matched analysis (n=490 in each group), the primary outcome occurred in 71 patients (14.5%) in the preintervention group compared with 36 patients (7.4%) in the intervention group (adjusted odds ratio 0.47; 95% confidence interval [CI] 0.31 to 0.71). There was an increase in ventilator-free days (mean difference 3.7; 95% CI 2.3 to 5.1), ICU-free days (mean difference 2.4; 95% CI 1.0 to 3.7), and hospital-free days (mean difference 2.4; 95% CI 1.2 to 3.6) associated with the intervention. The mortality rate was 34.1% in the preintervention group and 19.6% in the intervention group (adjusted odds ratio 0.47; 95% CI 0.35 to 0.63).

Conclusion

Implementing a mechanical ventilator protocol in the ED is feasible and is associated with significant improvements in the delivery of safe mechanical ventilation and clinical outcome.

Introduction

Annually, approximately 250,000 patients receive mechanical ventilation in US emergency departments (ED), many of whom have protracted lengths of stay while awaiting ICU admission.1, 2 Pulmonary complications, such as acute respiratory distress syndrome and ventilator-associated conditions, develop in more than 20% of ED patients receiving ventilation and adversely affect outcome and resource use.3, 4, 5, 6, 7, 8, 9 Because there is increased focus on reducing complications in this high-risk cohort, the time spent in the ED represents a vulnerable period in which preventive therapies could have a significant effect. However, the ED has not been targeted as an arena for prevention.10

Editor’s Capsule Summary

What is already known on this topic

Patients intubated in the emergency department (ED) are at risk for subsequent acute respiratory distress syndrome and other ventilator-associated complications.

What question this study addressed

Can a 4-part “lung-protective” mechanical ventilation protocol decrease the frequency of such complications?

What this study adds to our knowledge

In this before-and-after analysis of 980 intubated ED adults, the frequency of acute respiratory distress syndrome and other ventilator-associated complications decreased after protocol implementation (14.5% to 7.4%), as did mortality (34.1% to 19.6%).

How this is relevant to clinical practice

Although outcome improvement caused by factors other than the intervention cannot be excluded, these data support the efficacy of a 4-part lung-protective protocol.

Lung-protective ventilation, by reducing ventilator-associated lung injury, is one important strategy to aid in prevention of pulmonary complications. Although lung-protective ventilation is associated with a lower incidence of acute respiratory distress syndrome, evidence demonstrates that potentially injurious ventilator practices are common in the ED.4, 5, 8, 9, 11 Lung-protective ventilation in the ED may be effective at reducing pulmonary complications for several reasons. Experimental data have established that ventilator-associated lung injury can occur shortly after the initiation of mechanical ventilation.12, 13 This is supported by evidence showing that initial ventilator settings influence outcome in patients with, and at risk for, acute respiratory distress syndrome.3, 8, 9, 14 Even if delivered for comparatively brief periods, early lung-protective ventilation during vulnerable periods seems to carry subsequent benefit, as demonstrated by data from the operating room and in lung donation.15, 16 Finally, initial ventilator settings influence the future delivery of lung-protective ventilation; it is therefore possible that establishing a lung-protective strategy during the earliest phases of respiratory failure can improve downstream adherence to lung-protective ventilation.14

The objective of this study was to evaluate the effectiveness of an ED-based lung-protective mechanical ventilation protocol on reducing the incidence of pulmonary complications. Given the high risk of pulmonary complications in mechanically ventilated ED patients, low adherence to lung-protective ventilation, and the association between initial ventilator settings and outcome, we hypothesized that a multifaceted strategy aimed at improving ED mechanical ventilation practices would reduce the incidence of pulmonary complications after ICU admission from the ED.

Section snippets

Study Design and Setting

The Lung-Protective Ventilation Initiated in the Emergency Department (LOV-ED) trial was a quasi-experimental, before-after study. It consisted of a preintervention period (September 2009 to January 2014), a run-in period of approximately 6 months, during which lung-protective ventilation was implemented as the standard approach in the ED, and an intervention period (October 2014 to March 2016). The study was approved with waiver of informed consent because lung-protective ventilation in the ED

Characteristics of Study Subjects

Figure 2 presents the study flow diagram and the final study population.

Baseline characteristics of the study population are shown in Table 1. Matching on the propensity score allowed the selection of 490 pairs of patients with greater similarity in illness severity and clinically relevant predictors of the primary outcome. After the propensity match, there was a significance difference between the 2 groups in patients with dialysis dependence and those intubated as a result of congestive heart

Limitations

There are several limitations to the present study. A before-after study design is prone to temporal trends that may lead to independent changes in care. Analysis of secular changes did not demonstrate this; the greatest change in clinical practice and outcomes was isolated to the intervention period. However, unmeasured confounders that improved overall care during the intervention may have accounted for some of the improved outcomes. The study design can raise concern over proof of causation.

Discussion

The rationale for implementing lung-protective ventilation in the ED hinges on the premise that there is a temporal link between ventilator management during the earliest period of respiratory failure and the development of subsequent complications; early adherence to lung-protective ventilation could therefore improve outcome. Multiple studies show a link between nonprotective ventilation in the ICU and acute respiratory distress syndrome incidence, with syndrome onset typically 2 days after

References (43)

  • A. Neto et al.

    Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis

    JAMA

    (2012)
  • R. Spragg et al.

    Beyond mortality: future clinical research in acute lung injury

    Am J Respir Crit Care Med

    (2010)
  • R. Determann et al.

    Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial

    Crit Care

    (2010)
  • H.H. Webb et al.

    Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure

    Am Rev Respir Dis

    (1974)
  • D. Dreyfuss et al.

    High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure

    Am Rev Respir Dis

    (1988)
  • D.M. Needham et al.

    Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study

    Am J Respir Crit Care Med

    (2015)
  • E. Futier et al.

    A trial of intraoperative low-tidal-volume ventilation in abdominal surgery

    N Engl J Med

    (2013)
  • L. Mascia et al.

    Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial

    JAMA

    (2010)
  • B.M. Fuller et al.

    Lung-Protective Ventilation Initiated in the Emergency Department (LOV-ED): a study protocol for a quasi-experimental, before-after trial aimed at reducing pulmonary complications

    BMJ Open

    (2016)
  • Acute respiratory distress syndrome

    JAMA

    (2012)
  • J. Vincent et al.

    The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

    Intensive Care Med

    (1996)
  • Cited by (80)

    View all citing articles on Scopus

    Please see page 407 for the Editor’s Capsule Summary of this article.

    Supervising editor: Steven M. Green, MD

    Author contributions: BMF, ITF, RSH, and MHK were responsible for study concept and design. BMF, ITF, RJS, CCB, and AAK were responsible for acquisition of data and administrative, technical, or material support. BMF was responsible for management of data and quality control, drafting of the article, and statistical analysis. BMF, ITF, NMM, RSH, and MHK were responsible for analysis and interpretation of data. BMF, ITF, NMM, AMD, CP, BTW, EA, JK, RJS, CCB, AAK, RSH, and MHK were responsible for critical revision and final approval of the article. BMF and MHK were responsible for study supervision. BMF takes responsibility for the paper as a whole.

    All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

    Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. Drs. Fuller and Drewry were funded by the KL2 Career Development Award, and this research was supported by the Washington University Institute of Clinical and Translational Sciences (grants UL1 TR000448 and KL2 TR000450) from the National Center for Advancing Translational Sciences (NCATS). Dr. Fuller was also funded by the Foundation for Barnes-Jewish Hospital Clinical and Translational Sciences Research Program (grant 8041-88). Dr. Drewry was also funded by the Foundation for Anesthesia Education and Research. Dr. Mohr was supported by grant funds from the Emergency Medicine Foundation and the Health Resources and Services Administration. Dr. Ablordeppey was supported by the Washington University School of Medicine Faculty Scholars grant and the Foundation for Barnes-Jewish Hospital. Mr. Stephens was supported by the Clinical and Translational Science Award program of the NCATS of the National Institutes of Health (NIH) under awards UL1 TR000448 and TL1 TR000449. Mr. Briscoe was supported by the Short-Term Institutional Research Training Grant, NIH T35 (National Heart, Lung, and Blood Institute [NHLBI]). Dr. Hotchkiss was supported by NIH grants R01 GM44118-22 and R01 GM09839. Dr. Kollef was supported by the Barnes-Jewish Hospital Foundation.

    Trial registration number: clinicaltrials.gov NCT02543554

    The funders played no role in the following: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article.

    Readers: click on the link to go directly to a survey in which you can provide feedback to Annals on this particular article.

    View full text